相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis and in vitro anti-HSV-1 activity of a novel Hsp90 inhibitor BJ-B11
Huai-Qiang Ju et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC
N. R. Christoffersen et al.
CELL DEATH AND DIFFERENTIATION (2010)
Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening
Lian Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
S. Chandarlapaty et al.
ONCOGENE (2010)
Dynamics of heat shock protein 90 C-terminal dimerization is an important part of its conformational cycle
C. Ratzke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
Yutaka Okawa et al.
BLOOD (2009)
Antiproliferative and apoptotic activities of tosylcyclonovobiocic acids as potent heat shock protein 90 inhibitors in human cancer cells
Christine Radanyi et al.
CANCER LETTERS (2009)
Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235
Douglas W. McMillin et al.
CANCER RESEARCH (2009)
CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
Rudi Bao et al.
CLINICAL CANCER RESEARCH (2009)
Targeting Heat-Shock Protein 90 Improves Efficacy of Rapamycin in a Model of Hepatocellular Carcinoma in Mice
Sven A. Lang et al.
HEPATOLOGY (2009)
Hsp90 Regulates the Function of Argonaute 2 and Its Recruitment to Stress Granules and P-Bodies
Justin M. Pare et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib
Ching Ching Leow et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
Eloisi Caldas-Lopes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
ROMIDEPSIN FOR THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
Clara Campas-Moya
DRUGS OF TODAY (2009)
The Hsp90 molecular chaperone: an open and shut case for treatment
Laurence H. Pearl et al.
BIOCHEMICAL JOURNAL (2008)
NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
Suzanne A. Eccles et al.
CANCER RESEARCH (2008)
Control of cell proliferation pathways by microRNAs
Maria Jose Bueno et al.
CELL CYCLE (2008)
SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers
Sarat Chandarlapaty et al.
CLINICAL CANCER RESEARCH (2008)
Targeting Akt and heat shock protein 90 produces synergistic multiple myeloma cell cytotoxicity in the bone marrow microenvironment
Alissa Huston et al.
CLINICAL CANCER RESEARCH (2008)
Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-binding Pocket
Alison Donnelly et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Targeting Hsp90: small-molecule inhibitors and their clinical development
Tony Taldone et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Quercetin-induced ubiquitination and down-regulation of Her-2/neu
Jae-Hoon Jeong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Optimizing natural products by biosynthetic engineering: Discovery of nonquinone Hsp90 inhibitors
Ming-Qiang Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Molecular characterization of macbecin as an Hsp90 inhibitor
Christine J. Martin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells
Qun Zhou et al.
MOLECULAR CANCER RESEARCH (2008)
HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair
Thuy T. Koll et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer
Dongweon Song et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function
Shashwati Basak et al.
MOLECULAR CANCER THERAPEUTICS (2008)
被撤回的出版物: Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin (Retracted article. See vol. 34, pg. 1722, 2020)
L. X. Wu et al.
LEUKEMIA (2008)
Targeting RAS and PI3K in lung cancer
Julian Downward
NATURE MEDICINE (2008)
AP4 encodes a c-MYC-inducible repressor of p21
Peter Jung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion
S. Tsutsumi et al.
ONCOGENE (2008)
Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin
Alison Maloney et al.
CANCER RESEARCH (2007)
Translocation of heparanase into nucleus results in cell differentiation
Tetsuji Nobuhisa et al.
CANCER SCIENCE (2007)
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues
Swee Y. Sharp et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Regulation of c-Src activity by the expression of wild-type v-Src and its kinase-dead double Y416F-K295N mutant
Martina Vojtechova et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
The middle domain of Hsp90 acts as a discriminator between different types of client proteins
Patricija Hawle et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Differentially active origins of DNA replication in tumor versus normal cells
Domenic Di Paola et al.
CANCER RESEARCH (2006)
被撤回的出版物: Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT (Retracted article. See vol. 17, pg. 2075, 2018)
Nivedita Sain et al.
MOLECULAR CANCER THERAPEUTICS (2006)
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells
Yukihiro Akao et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Heat shock proteins in cancer: chaperones of tumorigenesis
SK Calderwood et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Angiostatic activity of DNA methyltransferase inhibitors
DMEI Hellebrekers et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The HSP90 family of genes in the human genome: Insights into their divergence and evolution
B Chen et al.
GENOMICS (2005)
Ribo-gnome: The big world of small RNAs
PD Zamore et al.
SCIENCE (2005)
Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway
MT McCabe et al.
CANCER RESEARCH (2005)
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
C Grandori et al.
NATURE CELL BIOLOGY (2005)
HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses
A Vendeville et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Geldanamycin, an inhibitor of the chaperone activity of hsp90, induces mapk-independent cell cycle arrest
M Bedin et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37
Y Miyata et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol
Y Ikuina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Identification of a cis-element that determines autonomous DNA replication in eukaryotic cells
GB Price et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Unexpected induction of the human connexin 43 promoter by the Ras signaling pathway is mediated by a novel putative promoter sequence
GD Carystinos et al.
MOLECULAR PHARMACOLOGY (2003)
Direct activation of RNA polymerase III transcription by c-Myc
N Gomez-Roman et al.
NATURE (2003)
Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1
N Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90 - N-terminal nucleotide binding unmasks a C-terminal binding pocket
C Soti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells
C Li et al.
ONCOGENE (2001)
Specific association of a set of molecular chaperones including HSP90 and Cdc37 with MOK, a member of the mitogen-activated protein kinase superfamily
Y Miyata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
